Fig. 7. SWIR fluorescence (>1000 nm) images of breast tumours treated with (a) and without (b) Kadcyla (0.2 mg). Kadcyla was intravenously injected to a breast-tumour bearing mouse two days after the injection of ICG–Herceptin. The images were taken 0, 3, 6, and 9 days after the injection of Kadcyla. Scale bar: 1 mm. Ex vivo bright field images of breast tumours were taken for the 9 day-mice after the treatment of Kadcyla. Scale bar: 5 mm.
